<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical outcome was evaluated in 43 patients with a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> or <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> and a bone marrow clone containing a single chromosome abnormality: <z:mp ids='MP_0004026'>monosomy</z:mp> 7/del(7q), <z:mp ids='MP_0004027'>trisomy</z:mp> 8, i(17q), del(5q), del(20q), or a t(2;11) </plain></SENT>
<SENT sid="1" pm="."><plain>Those with one of the first three abnormalities (22 patients) had shorter survival, more frequent progression to <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and less response to treatment with <z:chebi fb="0" ids="6067">13-Cis-retinoic acid</z:chebi> than did those in the latter three groups (21 patients) </plain></SENT>
<SENT sid="2" pm="."><plain>Additional data on these subgroups of preleukemic patients may confirm the prognostic value of such karyotypic information </plain></SENT>
</text></document>